Robert Mair

Dr. Robert Mair


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2010 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
RARobert C Axtell
Robert C Axtell
BJBrigit A de Jong
Brigit A de Jong
KBKatia Boniface
Katia Boniface
LVLaura F van der Voort
Laura F van der Voort
RBRoopa Bhat
Roopa Bhat
CRChander Raman
Chander Raman

7 August 2018 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
RMRobert Mair
Robert Mair
TSTammy L. Sirich
Tammy L. Sirich
NPNatalie S. Plummer
Natalie S. Plummer
TMTimothy W. Meyer
Timothy W. Meyer
Background and objectives: Colon microbial metabolism produces solutes that are normally excreted in the urine and accumulate in the plasma when the kidneys fail. This study sought to further identify and characterize human colon-derived uremic solutes. Design, setting, participants, & measurements: Colon-derived solutes normally excreted in the urine were identified by comparing urine from controls (n=17) and patients with total colectomies (n=12), using an established metabolomic platform. Colon-derived solutes that accumulate in kidney failure were then identified by comparing the plasma of the control patients with that of patients on dialysis (n=14). Results: Ninety-one urinary solutes were classified as colon-derived on the basis of the finding of a urine excretion rate at least four-fold higher in control patients than in patients with total colectomies. Forty-six were solutes with known chemical structure, 35 of which had not previously been identified as colon-derived. Sixty of the colon-derived solutes accumulated in the plasma of patients with ESKD to a degree greater than urea and were therefore classified as uremic. The estimated urinary clearance for 27 out of the 32 colon-derived solutes for which clearance could be calculated exceeded that of creatinine, consistent with tubular secretion. Sulfatase treatment revealed that 42 out of the 91 colon-derived solutes detected were likely conjugates. Conclusions: Metabolomic analysis identified numerous colon-derived solutes that are normally excreted in human urine. Clearance by tubular secretion limits plasma levels of many colon-derived solutes.

22 July 2011 in Hippocampus
Verified
Journal Article
Closed access
PDF file
JHJacqueline R. Hembrook
Jacqueline R. Hembrook
RMRobert Mair
Robert Mair

2 June 2018 in Toxins
Verified
Journal Article
Open access
PDF file
RMRobert Mair
Robert Mair
TSTammy Sirich
Tammy Sirich
TMTimothy Meyer
Timothy Meyer
Uremic solutes contribute to cardiovascular disease in renal insufficiency. In this review we describe the clearance of selected uremic solutes, which have been associated with cardiovascular disease. These solutes—indoxyl sulfate (IS), p-cresol sulfate (PCS), phenylacetylglutamine (PAG), trimethylamine-n-oxide (TMAO), and kynurenine—exemplify different mechanisms of clearance. IS and PCS are protein-bound solutes efficiently cleared by the native kidney through tubular secretion. PAG and TMAO are not protein-bound but are also cleared by the native kidney through tubular secretion, while kynurenine is not normally cleared by the kidney. Increases in the plasma levels of the normally secreted solutes IS, PCS, TMAO, and PAG in chronic kidney disease (CKD) are attributable to a reduction in their renal clearances. Levels of each of these potential toxins are even higher in patients on dialysis than in those with advanced chronic kidney disease, which can be accounted for in part by a low ratio of dialytic to native kidney clearance. The rise in plasma kynurenine in CKD and dialysis patients, by contrast, remains to be explained. Our ability to detect lower levels of the potential uremic cardiovascular toxins with renal replacement therapy may be limited by the intermittency of treatment, by increases in solute production, and by the presence of non-renal clearance. Reduction in the levels of uremic cardiovascular toxins may in the future be achieved more effectively by inhibiting their production.

3 May 2011 in Hippocampus
Verified
Journal Article
Closed access
PDF file
JHJacqueline R. Hembrook
Jacqueline R. Hembrook
KOKristen D. Onos
Kristen D. Onos
RMRobert Mair
Robert Mair

24 December 2008 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
RMRobert Mair
Robert Mair
JHJacqueline R. Hembrook
Jacqueline R. Hembrook
The rostral intralaminar thalamic nuclei (ILn) are organized to activate pathways originating in medial prefrontal cortex (mPF) that mediate memory-guided responding during alert, wakeful states. Previous studies have shown that rostral ILn or mPF lesions produce deficits in delayed matching to position (DMTP). Here, we manipulated rostral ILn activity in rats by microinjecting drugs or applying electrical current and examined effects on DMTP. Inhibiting activity with the GABAAagonist muscimol impaired DMTP. Decreasing GABAAtone with FG-7142 (N-methyl-β-carboline-3-carboxamide) improved DMTP at low but not high doses. Orexin A, which depolarizes thalamocortical neurons locally within the ILn, improved DMTP, whereas the cholinergic agonist carbachol impaired performance at the highest dose tested. These drug effects were unaffected by partial mPF lesions in a subset of animals. Microinjection results are consistent with an inverted-U relationship between thalamic activity and DMTP. This relationship was confirmed by event-related electrical stimulation, which produced improvement at low stimulation currents and impairment at higher currents. Electrical stimulation affected DMTP when applied at the start of the memory delay or choice response, but not earlier when trials began or the sample lever was presented. Our results are consistent with evidence that the rostral ILn play a role in retrieval, carrying response-related information across brief memory delays and facilitating memory-guided responding. They also provide evidence that treatments stimulating rostral ILn activity may be an effective means to enhance working memory and related cognitive processes and thus to treat disorders that affect these functions.